OTHER · Unmapped registry intervention
Genetic: DNA analysis
Find medicine records ·
Find other trials using this name
Clinical trial
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
NCT06953180
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedEpigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Cardiovascular Diseases (CVD)unresolved
Chronic Respiratory Diseasesunresolved
Obesity (Disorder)candidate · MONDO: obesity disorder
Chronic Kidney Diseasesunresolved
Interventions
Sponsors & collaborators
Asfendiyarov Kazakh National Medical Universitylead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06953180 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.